InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: C-20 post# 154056

Monday, 03/22/2021 2:05:52 PM

Monday, March 22, 2021 2:05:52 PM

Post# of 233221

Name one better . You can’t.



HGEN's lenzilumab is going to blow the doors off of leronlimab's trial. Lenzilumab is a GM-CSF inhibitor. Scientists recently discovered that GM-CSF is the cytokine responsible for severe Covid and death. Here are links to 2 articles discussing GM-CSF's role in Covid and a link to the study.

https://www.bbc.com/news/health-56352128

https://www.dailymail.co.uk/news/article-9346955/Blood-test-spot-Covid-patients-high-risk-dying.html

https://immunology.sciencemag.org/content/6/57/eabg9873
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News